Suppurative Hidradenitis: Imagining Future Transitions
Welcome to EHSF 2024
Welcome to the 13th edition of the European Hidradenitis Suppurativa Foundation Conference in Lyon!
With the emergence of innovative biologics, combined with surgical strategies, the HS community is undergoing a remarkable revolution. The EHSF is the congress to discuss cutting edge data and emergent therapeutic strategies in HS; with the latest revelations in clinical and fundamental research, or the most ardent debates on diagnostic and treatments.
Axel VILLANI, MD, PhD
Professor
Dept of Dermatology,
Hôpital Edouard Herriot,
Hospices Civils de Lyon
Philippe GUILLEM, MD, PhD
Dept of Surgery,
Clinique du Val d’Ouest,
Ecully
- Catch up with HS moving world
- Get the latest news from international experts
- Biologic agents era
- First live surgery session at the EHSF meeting
- A meeting open to nurses and patients
Axel VILLANI, MD, PhD, Professor
Dept of Dermatology, Hôpital Edouard Herriot, Hospices Civils de Lyon
Centre International de Recherche en Infectiologie, Université Claude Bernard Lyon 1, Inserm U1111, CNRS, UMR5308, ENS Lyon
Philippe GUILLEM, MD, PhD
Dept of Surgery,
Clinique du Val d’Ouest,
Ecully
- Denis Jullien (MD, PhD)
- Marie Aleth Richard (MD, PhD)
- Ziad Reguiai (MD)
- The Société Française de Dermatologie (SFD)
- The workgroup HS-France from the SFD
- The RésoVerneuil
- The association REVVOL
Registration for EHSF Conference 2024
Stay updated on the most recent trends and emerging scientific breakthroughs, and get ready to delve into the innovations of the future!
Registration will open 01 October 2023.
Call for Abstracts
Seize the opportunity to play an active role in the next EHSF Conference and contribute to the scientific program by submitting your abstract and sharing your latest research. Abstracts on on-going trials are encouraged. Abstracts will be published in a supplement of Experimental Dermatology.
Kindly note: The registration for the conference is mandatory for each presenting author in order for the abstract to be presented and published.
Abstract Topics
Epidemiology and diagnostic tools ■ Genetics ■ Immunology ■ Pathogenesis ■ Comorbidities ■ Imaging ■ Outcome measures ■ Medical treatment ■ Surgical treatment ■ Nursing ■ Quality of life and unmet needs ■ New from clinical trials ■ New advancements in research ■ Others
The official congress language is English.
General
Information
about the